Developer docs
API playgroundTry for free, no card

Search company profiles

Northlane Capital Partners

Full company profile

uuid00007va

Namestring
Northlane Capital Partners
Legal namestring
Northlane Capital Partners
Company typeenum
Private
Founded yearint
2003
Descriptiontext

Northlane Capital Partners is a Bethesda, Maryland-based private equity firm that has invested exclusively in middle-market healthcare and business services companies since its principals began working together in 2003. The firm targets profitable, growing companies with enterprise values of $50 million to $350 million and EBITDA of $5 million to $30 million, deploying equity checks of $25 million to $150 million. Across three sequential funds and more than 100 investments, Northlane has invested over $1.9 billion cumulatively and completed more than 80 add-on transactions for portfolio companies, executing a focused platform-and-roll-up strategy in sub-verticals including behavioral health, dental services, employer health benefits, healthcare IT, lab services, medical device outsourcing, pharmaceutical services, insurance, legal, and HR outsourcing.

The firm has no proprietary technology product; its operating model functions as an outsourced corporate development arm for management teams, providing capital, sub-vertical expertise, M&A execution (including add-on sourcing and integration), and an executive network used to recruit operators and board members. Revenue is generated through conventional private equity economics — management fees on committed capital across its fund vehicles and carried interest on realizations — with Fund III having closed at a $750 million hard cap in October 2025, materially above its $550 million target.

Distribution and deal sourcing are almost entirely relationship-driven: the firm relies on its executive network, founder referrals, and industry events rather than competitive auctions or broad digital marketing. The investor base is a diversified set of global institutional LPs, while the firm's "customers" are the founders and management teams of portfolio companies it partners with for multi-year value creation before exiting via strategic or sponsor-to-sponsor transactions.

Short descriptiontext

Northlane Capital Partners is a Bethesda, Maryland-based private equity firm investing $25M–$150M of equity in profitable middle-market healthcare and business services companies with $50M–$350M enterprise value and $5M–$30M EBITDA, having closed Fund III at $750M.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
11–50
akta.pro rankint
HeadquartersBethesda, United States
HQ citystring
Bethesda
HQ countrystring
United States
HQ regionstring
North America
Markets served

Serves global market

Offices1 record

Each record includes

City, Country, Type, Description, Source

Keyword5 values
middle market private equity, healthcare private equity, business services investing, private equity fund management, middle market buyouts
Industry2 codes
PRIMARYFSANABAB
Mid-Market Buyout
SECONDARYFSANACAD
Business Services (B2B) Growth Equity
NAICS code3 codes
  • Other Financial Investment Activities5239
  • Funds, Trusts, and Other Financial Vehicles525
  • Securities, Commodity Contracts, and Other Financial Investments and Related Activities523
SIC code1 code
  • Investors, Nec6799
Product category
Private Equity Fund Management
Social media profiles1 record
GTM motion2 records

Each record includes

Type, Description, Source

Revenue model1 record
1Private Equity Management and Performance Fees
TypeManaged Services
Description

As a private equity firm, Northlane generates revenue through management fees on committed capital and carried interest (performance fees) on investment returns. Fund III closed at $750 million, attracting diverse global investors.

northlanecapital.com
Marketing channels4 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels1 record

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components5 values
Personnel, Operations, Marketing or Sales, Infrastructure, Technology or R&D
GTM typeB2B
B2B
Offering typeServices
Services
Core offering1 text field

Northlane Capital Partners is a middle-market private equity firm that invests equity capital of $25 to $150 million in healthcare and business services companies with enterprise values of $50 to $350 million and EBITDA of $5 to $30 million. The firm partners with management teams as an outsourced corporate development function, executing add-on acquisitions and providing strategic and operational support through its executive network. Its third fund, Northlane Capital Partners III LP, closed at $750 million in October 2025.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 3 values shown
  • 100+ investments completed with $1.9B invested
+2 more records
Product overview1 text field

Northlane Capital Partners is a middle-market private equity firm offering a single private equity fund structure (Northlane Capital Partners III LP at $750 million) that invests in healthcare and business services companies. The firm does not offer a unified software platform but rather manages a diversified portfolio of 30+ portfolio companies across sectors including healthcare services, business services, insurance, legal technology, education technology, and pharmaceutical services. The portfolio includes platform investments like File & ServeXpress (court technology), Choice Financial Group (insurance), Firma Clinical Research (CRO services), Infobase (educational solutions), PAR Excellence Systems (healthcare supply chain), SAI MedPartners (pharma consulting), USDTL (toxicology testing), and others, representing the firm's investment holdings rather than a product suite.

Product and service2 records
1Northlane Capital Partners III LP
CategoryPrivate Equity Fund
2Private Equity Investment Management Services
CategoryInvestment Management Services
Scale indicator10 records

Each record includes

Type, Value, Description, Source

Partnership4 partners
Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2026-03-05
Description

Northlane completed an investment in File & ServeXpress alongside the FSX management team led by CEO Tammy Carter. The partnership aims to support the company's continued growth in the court technology sector, leveraging government technology infrastructure modernization and AI integration opportunities.

Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2025-06-30
Description

Northlane sold The Difference Card, a provider of healthcare cost containment solutions. The transaction was part of Northlane's ongoing portfolio management and exit strategy.

3Plus Delta Partners Management
Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2025-01-27
Description

Northlane invested in Plus Delta Partners, a leading provider of specialized fundraising training and tools for higher education institutions, healthcare organizations, and nonprofits. The partnership supports the company's growth initiatives.

northlanecapital.com
4United States Drug Testing Laboratories (USDTL) Management
Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2025-01-07
Description

Northlane invested in USDTL, a forensic toxicology laboratory specializing in testing for alcohol and substance use in newborns, children, and adults. The partnership supports the company's growth in the toxicology testing market.

northlanecapital.com
Recent move7 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight6 records

Each record includes

Type, Description

Peers10 records
TypeDirect peer
Description

Chicago-based private equity firm exclusively focused on healthcare, partnering with management teams to invest in middle-market healthcare companies. Direct peer with whom Northlane has already partnered on the Advarra formation.

TypeDirect peer
Description

Middle-market private equity firm investing in healthcare, business services, and specialty industrials, with a similar size range and founder/management partnership model as Northlane.

TypeDirect peer
Description

Healthcare-focused private equity firm investing in middle-market healthcare services, life sciences, and healthcare technology companies. Direct healthcare sector peer at similar deal scale.

TypeDirect peer
Description

One of the oldest healthcare-focused PE firms, investing across healthcare services and products at growth and buyout stages. Established healthcare PE specialist with overlapping sub-vertical coverage.

TypeDirect peer
Description

Middle-market private investment firm focused on business services, healthcare, and consumer companies. Directly comparable in size, sector mix, and lower middle market buyout approach.

TypeDirect peer
Description

Pittsburgh-based middle-market PE firm investing in healthcare, business services, and consumer products. Already a counterparty to Northlane on the VMG Health exit.

TypeDirect peer
Description

Middle-market private equity firm investing in healthcare, business services, and consumer companies through control buyouts. Counterparty to Northlane on the Empower Community Care exit.

TypeDirect peer
Description

Middle-market PE firm focused on technology-enabled services in healthcare, financial services, and government. Acquired PAR Excellence from Northlane in 2024.

TypeDirect peer
Description

Healthcare-focused middle-market private equity firm investing across healthcare services, products, and technology. Closely comparable by sector specialization and lower middle market positioning.

TypeBroad incumbent
Description

Larger growth-oriented investment firm with significant healthcare services, healthcare IT, and business services exposure. Operates at a higher AUM scale but overlaps substantially on Northlane's target sub-verticals.

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat4 records

Each record includes

Type, Details

Key risks6 records

Each record includes

Headline, Details, Source

Key highlights7 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers10 records

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment3 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile2 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
No
API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles7 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

No data
No data
Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A2 records

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment13 records

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Northlane Capital Partners

Private Equity Fund Managementnorthlanecapital.com

Northlane Capital Partners is a Bethesda, Maryland-based private equity firm investing $25M–$150M of equity in profitable middle-market healthcare and business services companies with $50M–$350M enterprise value and $5M–$30M EBITDA, having closed Fund III at $750M.

What Northlane Capital Partners does

Northlane Capital Partners is a Bethesda, Maryland-based private equity firm that has invested exclusively in middle-market healthcare and business services companies since its principals began working together in 2003. The firm targets profitable, growing companies with enterprise values of $50 million to $350 million and EBITDA of $5 million to $30 million, deploying equity checks of $25 million to $150 million. Across three sequential funds and more than 100 investments, Northlane has invested over $1.9 billion cumulatively and completed more than 80 add-on transactions for portfolio companies, executing a focused platform-and-roll-up strategy in sub-verticals including behavioral health, dental services, employer health benefits, healthcare IT, lab services, medical device outsourcing, pharmaceutical services, insurance, legal, and HR outsourcing.

The firm has no proprietary technology product; its operating model functions as an outsourced corporate development arm for management teams, providing capital, sub-vertical expertise, M&A execution (including add-on sourcing and integration), and an executive network used to recruit operators and board members. Revenue is generated through conventional private equity economics — management fees on committed capital across its fund vehicles and carried interest on realizations — with Fund III having closed at a $750 million hard cap in October 2025, materially above its $550 million target.

Distribution and deal sourcing are almost entirely relationship-driven: the firm relies on its executive network, founder referrals, and industry events rather than competitive auctions or broad digital marketing. The investor base is a diversified set of global institutional LPs, while the firm's "customers" are the founders and management teams of portfolio companies it partners with for multi-year value creation before exiting via strategic or sponsor-to-sponsor transactions.

Northlane Capital Partners firmographics

Firmographics
Name
Northlane Capital Partners
Legal name
Northlane Capital Partners
Website
https://northlanecapital.com
Company type
Private
Founded year
2003
Operating status
Operating
Headcount range
11–50 employees
Short description
Northlane Capital Partners is a Bethesda, Maryland-based private equity firm investing $25M–$150M of equity in profitable middle-market healthcare and business services companies with $50M–$350M enterprise value and $5M–$30M EBITDA, having closed Fund III at $750M.
Ownership category
akta.pro rank

Northlane Capital Partners industry classification

Industry
Product category
Private Equity Fund Management
NAICS
Other Financial Investment Activities (5239), Funds, Trusts, and Other Financial Vehicles (525), Securities, Commodity Contracts, and Other Financial Investments and Related Activities (523)
SIC
Investors, Nec (6799)
akta.pro industry
PRIMARYFSANABAB
Mid-Market Buyout
SECONDARYFSANACAD
Business Services (B2B) Growth Equity

Keywords

  • Middle market private equity
  • Healthcare private equity
  • Business services investing
  • Private equity fund management
  • Middle market buyouts

Where Northlane Capital Partners is headquartered

Location

Headquarters

HQ city
Bethesda
HQ country
United States
HQ region
North America

Offices1 record

Markets served

Northlane Capital Partners business model

Business model
GTM type
B2B
Offering type
Services
Cost components
Personnel, Operations, Marketing or Sales, Infrastructure, Technology or R&D

Revenue model

  1. Private Equity Management and Performance Fees: As a private equity firm, Northlane generates revenue through management fees on committed capital and carried interest (performance fees) on investment returns. Fund III closed at $750 million, attracting diverse global investors.

Go-to-market motion2 records

Distribution channels1 record

Marketing channels4 records

Northlane Capital Partners product offering

Product offering

Core offering

Northlane Capital Partners is a middle-market private equity firm that invests equity capital of $25 to $150 million in healthcare and business services companies with enterprise values of $50 to $350 million and EBITDA of $5 to $30 million. The firm partners with management teams as an outsourced corporate development function, executing add-on acquisitions and providing strategic and operational support through its executive network. Its third fund, Northlane Capital Partners III LP, closed at $750 million in October 2025.

Product overview

Northlane Capital Partners is a middle-market private equity firm offering a single private equity fund structure (Northlane Capital Partners III LP at $750 million) that invests in healthcare and business services companies. The firm does not offer a unified software platform but rather manages a diversified portfolio of 30+ portfolio companies across sectors including healthcare services, business services, insurance, legal technology, education technology, and pharmaceutical services. The portfolio includes platform investments like File & ServeXpress (court technology), Choice Financial Group (insurance), Firma Clinical Research (CRO services), Infobase (educational solutions), PAR Excellence Systems (healthcare supply chain), SAI MedPartners (pharma consulting), USDTL (toxicology testing), and others, representing the firm's investment holdings rather than a product suite.

Differentiator

Problem solved

Functional benefit

Products and services

  • Northlane Capital Partners III LP
  • Private Equity Investment Management Services

Quantifiable outcome

  • 100+ investments completed with $1.9B invested
  • +2 more outcomes

Companies that use Northlane Capital Partners

Customer profile

Named customers10 records

Segments3 records

Ideal customer profiles2 records

Northlane Capital Partners technology and API

Technology

Technology focussed No

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Northlane Capital Partners partnerships and signals

Strategic signal

Partnerships

Four partnerships are on record, tiered core.

  • File & ServeXpress Management Team (led by CEO Tammy Carter)coreStrategic or Co-development Partner · 5 March 2026Northlane completed an investment in File & ServeXpress alongside the FSX management team led by CEO Tammy Carter. The partnership aims to support the company's continued growth in the court technology sector, leveraging government technology infrastructure modernization and AI integration opportunities.
  • The Difference Card ManagementcoreStrategic or Co-development Partner · 30 June 2025Northlane sold The Difference Card, a provider of healthcare cost containment solutions. The transaction was part of Northlane's ongoing portfolio management and exit strategy.
  • Plus Delta Partners ManagementcoreStrategic or Co-development Partner · 27 January 2025Northlane invested in Plus Delta Partners, a leading provider of specialized fundraising training and tools for higher education institutions, healthcare organizations, and nonprofits. The partnership supports the company's growth initiatives.
  • United States Drug Testing Laboratories (USDTL) ManagementcoreStrategic or Co-development Partner · 7 January 2025Northlane invested in USDTL, a forensic toxicology laboratory specializing in testing for alcohol and substance use in newborns, children, and adults. The partnership supports the company's growth in the toxicology testing market.

Scale indicators10 records

Recent moves7 records

Expansion highlights6 records

Northlane Capital Partners competitors and assessment

Company assessment

Direct peers

  • Linden Capital Partners: Chicago-based private equity firm exclusively focused on healthcare, partnering with management teams to invest in middle-market healthcare companies. Direct peer with whom Northlane has already partnered on the Advarra formation.
  • Waud Capital Partners: Middle-market private equity firm investing in healthcare, business services, and specialty industrials, with a similar size range and founder/management partnership model as Northlane.
  • Martis Capital: Healthcare-focused private equity firm investing in middle-market healthcare services, life sciences, and healthcare technology companies. Direct healthcare sector peer at similar deal scale.
  • Frazier Healthcare Partners: One of the oldest healthcare-focused PE firms, investing across healthcare services and products at growth and buyout stages. Established healthcare PE specialist with overlapping sub-vertical coverage.
  • Comvest Partners: Middle-market private investment firm focused on business services, healthcare, and consumer companies. Directly comparable in size, sector mix, and lower middle market buyout approach.
  • Incline Equity Partners: Pittsburgh-based middle-market PE firm investing in healthcare, business services, and consumer products. Already a counterparty to Northlane on the VMG Health exit.
  • NexPhase Capital: Middle-market private equity firm investing in healthcare, business services, and consumer companies through control buyouts. Counterparty to Northlane on the Empower Community Care exit.
  • OceanSound Partners: Middle-market PE firm focused on technology-enabled services in healthcare, financial services, and government. Acquired PAR Excellence from Northlane in 2024.
  • Webster Equity Partners: Healthcare-focused middle-market private equity firm investing across healthcare services, products, and technology. Closely comparable by sector specialization and lower middle market positioning.

Broad incumbents

  • New Mountain Capital: Larger growth-oriented investment firm with significant healthcare services, healthcare IT, and business services exposure. Operates at a higher AUM scale but overlaps substantially on Northlane's target sub-verticals.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat4 records

Key risks6 records

Key highlights7 records

Customer concentration

Northlane Capital Partners social profiles

Digital presence

Northlane Capital Partners financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Northlane Capital Partners leadership team

Management profile

Number of profiles

Profiles7 records

Northlane Capital Partners funding detail

Funding detail

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Northlane Capital Partners M&A and investment

M&A and investment

M&A2 records

Investments13 records

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Northlane Capital Partners

What does Northlane Capital Partners do?

Northlane Capital Partners is a middle-market private equity firm that invests equity capital of $25 to $150 million in healthcare and business services companies with enterprise values of $50 to $350 million and EBITDA of $5 to $30 million. The firm partners with management teams as an outsourced corporate development function, executing add-on acquisitions and providing strategic and operational support through its executive network. Its third fund, Northlane Capital Partners III LP, closed at $750 million in October 2025.

Is Northlane Capital Partners a public or private company?

Northlane Capital Partners is a private company. It is classified as management employee owned and is currently operating.

When was Northlane Capital Partners founded?

Northlane Capital Partners was founded in 2003. It employs 11 to 50 people.

Where is Northlane Capital Partners based?

Northlane Capital Partners is headquartered in Bethesda, United States, in the North America region.

How does Northlane Capital Partners make money?

One revenue line is on record: private Equity Management and Performance Fees.

Who are Northlane Capital Partners's main competitors?

Direct peers on record are Linden Capital Partners, Waud Capital Partners, Martis Capital, Frazier Healthcare Partners, Comvest Partners, Incline Equity Partners, NexPhase Capital, OceanSound Partners and Webster Equity Partners. New Mountain Capital is listed as a broad incumbent.

Does Northlane Capital Partners have an API?

No public API is recorded for Northlane Capital Partners.

What industry is Northlane Capital Partners in?

Northlane Capital Partners's product category is Private Equity Fund Management. Its primary akta.pro industry code is FSANABAB, Mid-Market Buyout, with a secondary code of FSANACAD, Business Services (B2B) Growth Equity. Its NAICS code is 5239 and its SIC code is 6799.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals
GovtechGov Tech Biz Quarterly Roundup: Q1 2026 With Jeff CookQ1 2026 gov tech deal volume totaled $1.9 billion, down from $3.5 billion the prior quarter, with most deals completed in January before a market pause. Notable transactions include ClearGov-Gavity merger, Northlane's acquisition of File & ServeXpress, and Cambridge Mobile Telematics' $350 million raise. A backlog of deals is expected to reopen in Q2-Q4.openPR.comFuture Perspectives: Key Trends Shaping the Digital Healthcare Supply Chain Management Market Until 2030The digital healthcare supply chain management market is projected to reach $6.94 billion by 2030, growing at a compound annual growth rate of 11.9%, driven by AI-powered analytics, smart hospital adoption, and increasing regulatory emphasis on traceability. In September 2024, OceanSound Partners acquired PAR Excellence Systems Inc. from Northlane Capital Partners to strengthen its portfolio with healthcare supply chain integrity and cost management solutions. In May 2023, Olympus extended its partnership with US-based medical device company Endoclot to introduce hemostatic agents supporting safer gastrointestinal procedures.InfotechLeadM&A deals: Arrive, Sectra, Northlane Capital PartnersThree M&A deals were announced: Arrive acquired Passport, a parking management and payment software provider; Sectra acquired Oxipit, a medical imaging AI specialist; and Northlane Capital Partners acquired File & ServeXpress, a legal technology and digital court filing company. The acquisitions aim to expand each acquirer's technology platform in smart mobility, enterprise medical imaging, and legal technology respectively, with financial terms undisclosed for all three transactions. The deals reflect ongoing consolidation in B2B software sectors focused on AI, cloud platforms, and digital infrastructure.Dallas InnovatesIrving's File & ServeXpress Gets Investment From Maryland's Northlane CapitalIrving-based File & ServeXpress (FSX), a legal technology provider serving courts, government agencies, and legal professionals, has received an investment from Bethesda, Maryland-based private equity firm Northlane Capital Partners, with the amount undisclosed. The investment was made alongside FSX's management team led by CEO Tammy Carter. FSX operates in over 1,900 courts nationwide, manages more than 100 million documents, and serves over 200,000 registered users, representing the top 100 litigation firms in the U.S.FinSMEsFile & ServeXpress Receives Investment from Northlane Capital PartnersFile & ServeXpress, an Irving, TX-based document exchange and management provider, received an undisclosed investment from Northlane Capital Partners. The company's platform manages over 100 million documents, serves more than 200,000 users, and operates in over 1,900 courts nationwide.Pulse 2.0Northlane Capital Partners Invests In Court Technology Platform File & ServeXpressNorthlane Capital Partners has completed an investment in File & ServeXpress, a court technology platform providing online document exchange and management solutions for courts, government agencies, and legal professionals across the United States. The platform manages more than 100 million documents, serves over 200,000 registered users, and operates in more than 1,900 courts nationwide, including the top 100 litigation firms in the U.S. Northlane Capital Partners, a middle-market private equity firm, sees strong opportunity for File & ServeXpress as government technology infrastructure continues to modernize, including the integration of artificial intelligence capabilities.Business Wire BlogNorthlane Capital Partners Announces Investment in File & ServeXpressNorthlane Capital Partners completed an investment in File & ServeXpress, a provider of court technology solutions including online document exchange, data management, and notifications for courts, government agencies, and legal professionals across the United States. The investment was made alongside FSX's management team led by CEO Tammy Carter, with the partnership aimed at supporting FSX's continued growth and AI integration efforts. FSX currently manages more than 100 million documents, serves over 200,000 registered users, and operates in more than 1,900 courts nationwide.Venture Capital Access OnlineNorthlane Capital Partners Announces Investment in File & ServeXpressNorthlane Capital Partners announced it has completed an investment in File & ServeXpress, a provider of online document exchange and case management solutions for courts, government agencies, and legal professionals across the United States. The investment was made alongside the FSX management team led by CEO Tammy Carter, with the partnership aimed at supporting the company's continued growth in the court technology sector. FSX operates in more than 1,900 courts nationwide and serves over 200,000 registered users, managing more than 100 million documents.EIN PresswireNeonatal Toxicology Market to Reach USD 931.7 Million by 2035 Amid Rising Prenatal Substance Exposure - By TMRTransparency Market Research published a report showing the global neonatal toxicology market is projected to grow from $302.5 million in 2024 to $931.7 million by 2035, expanding at a 10.9% CAGR, driven by rising prenatal substance exposure and advancements in diagnostic technologies. North America led the market with 47.2% revenue share in 2024, while the cannabinoids segment held the largest share at 30.2%. Recent market developments include Labcorp's acquisition of select assets from Invitae in August 2024 and Northlane Capital Partners' acquisition of United States Drug Testing Laboratories in January 2025.MorningstarNorthlane Capital Partners Announces the Sale of The Difference CardNorthlane Capital Partners sold The Difference Card to funds managed by Stone Point Capital LLC. The healthcare cost containment provider, founded in 2001, has delivered billions in savings to clients. NCP cited the exit as an example of its investment strategy.